Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-11 Sale | 2024-03-12 1:41 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 11,509 | $49.93 | $574,644 | 252,823 (Direct) | View |
2024-03-07 Sale | 2024-03-11 12:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 12,195 | $50.88 | $620,443 | 14,860 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,756 | $53.76 | $201,923 | 98,740 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:19 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 1,011 | $53.76 | $54,351 | 295,732 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 4,173 | $53.76 | $224,340 | 120,668 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:13 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 341 | $53.76 | $18,332 | 51,931 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 1,238 | $53.76 | $66,555 | 85,478 (Direct) | View |
2024-03-01 Sale | 2024-03-05 8:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 4,768 | $53.76 | $256,328 | 101,363 (Direct) | View |
2024-02-07 Sale | 2024-02-08 3:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $45 | $1,350,000 | 2,803,755 (Indirect Direct) | View |
2023-12-29 Sale | 2024-01-02 4:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 30,000 | $47.87 | $1,436,100 | 2,833,755 (Indirect Direct) | View |
2023-10-23 Sale | 2023-10-24 5:22 pm | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $32.78 | $1,307,201 | 246,860 (Direct) | View |
2023-10-19 Sale | 2023-10-23 5:14 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $33.52 | $1,604,033 | 2,863,728 (Indirect Direct) | View |
2023-09-07 Sale | 2023-09-11 1:52 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,163 | $40.8 | $88,249 | 26,614 (Direct) | View |
2023-09-05 Sale | 2023-09-06 5:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 6,000 | $37.96 | $227,760 | 51,281 (Direct) | View |
2023-09-01 Sale | 2023-09-06 5:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 970 | $37.15 | $36,032 | 23,777 (Direct) | View |
2023-06-30 Sale | 2023-06-30 2:34 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 585 | $46.76 | $27,355 | 8,985 (Direct) | View |
2023-06-19 Sale | 2023-06-21 6:17 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 305 | $48.2 | $14,701 | 57,281 (Direct) | View |
2023-06-08 Sale | 2023-06-09 2:31 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 1,485 | $51.65 | $76,700 | 16,680 (Direct) | View |
2023-05-18 Sale | 2023-05-19 1:54 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 2,012 | $50 | $100,600 | 74,744 (Direct) | View |
2023-05-04 Sale | 2023-05-05 2:16 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 4,378 | $45 | $197,010 | 51,982 (Direct) | View |
2023-03-01 Sale | 2023-03-03 8:00 pm | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 3,881 | $45.25 | $175,615 | 46,720 (Direct) | View |
2023-03-01 Sale | 2023-03-03 7:59 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 3,161 | $45.25 | $143,035 | 95,539 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-03-01 Option Award | 2024-03-05 8:23 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 53,600 | $0 | 133,966 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:22 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 50,157 | $0 | 98,740 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:19 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 50,157 | $0 | 295,732 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 8:19 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 274 | $53.69 | 295,732 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:17 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 50,157 | $0 | 114,402 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 8:17 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 470 | $53.69 | 114,402 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:15 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 50,157 | $0 | 120,668 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 8:15 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 60 | $53.69 | 120,668 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:13 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 24,501 | $0 | 51,931 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 8:13 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 121 | $53.69 | 51,931 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:10 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 55,951 | $0 | 85,478 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:08 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 54,557 | $0 | 101,363 (Direct) | View |
2024-03-01 Option Award | 2024-03-05 8:06 pm | N/A 2034-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 111,654 | $0 | 2,897,992 (Direct) | View |
2024-03-01 Tax Withholding | 2024-03-05 8:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 17,417 | $53.69 | 2,897,992 (Direct) | View |
2024-01-02 Exercise | 2024-01-02 4:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $21 | 27,892 (Direct) | View |
2023-12-20 Option Award | 2024-01-02 4:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 1,000 | $0 | 27,892 (Direct) | View |
2024-01-02 Exercise | 2024-01-02 4:06 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $0 | 27,892 (Direct) | View |
2023-10-23 Exercise | 2023-10-24 5:22 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $6.86 | 246,860 (Direct) | View |
2023-10-23 Exercise | 2023-10-24 5:22 pm | N/A 2023-10-31 | Ultragenyx Pharmaceutical Inc. | RARE | Kassberg Thomas Richard CBO & EVP | 39,878 | $0 | 246,860 (Direct) | View |
2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $6.86 | 2,863,728 (Direct) | View |
2023-10-19 Exercise | 2023-10-23 5:14 pm | N/A 2023-11-01 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 47,853 | $0 | 2,863,728 (Direct) | View |
2023-10-09 Option Award | 2023-10-10 12:50 pm | N/A 2033-10-09 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 220,835 | $0 | 220,805 (Direct) | View |
2023-09-27 Option Award | 2023-09-29 2:16 pm | N/A 2027-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,351 | $0 | 25,965 (Direct) | View |
2023-09-27 Option Award | 2023-09-29 2:15 pm | N/A 2027-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 2,351 | $0 | 32,863 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 1:52 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,000 | $21 | 26,614 (Direct) | View |
2023-09-07 Exercise | 2023-09-11 1:52 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 2,000 | $0 | 26,614 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:33 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director | 10,970 | $0 | 19,390 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:32 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 10,970 | $0 | 34,165 (Direct) | View |
2023-06-07 Disposition | 2023-06-09 2:32 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 3,300 | $51.82 | 34,165 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:31 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 10,970 | $0 | 16,680 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:30 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 10,970 | $0 | 21,965 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:30 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director | 10,970 | $0 | 28,715 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:29 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 10,970 | $0 | 26,840 (Direct) | View |
2023-06-07 Option Award | 2023-06-09 2:28 pm | N/A 2033-06-07 | Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director | 10,970 | $0 | 28,715 (Direct) | View |
2023-05-09 Exercise | 2023-05-10 8:09 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $21 | 35,747 (Direct) | View |
2023-05-09 Exercise | 2023-05-10 8:09 pm | N/A 2024-01-29 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 3,000 | $0 | 35,747 (Direct) | View |
2023-05-01 Option Award | 2023-05-02 6:18 pm | N/A 2033-05-01 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 13,020 | $0 | 38,874 (Direct) | View |
Ownership | 2023-05-02 6:14 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 0 | $0 | 74,844 (Direct) | View |
2023-04-16 Disposition | 2023-04-18 4:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 181 | $38.2 | 27,520 (Direct) | View |
2023-04-16 Tax Withholding | 2023-04-18 4:57 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 14 | $38.2 | 27,520 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 8:00 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Bedrosian Camille L EVP and Chief Medical Officer | 2,663 | $0 | 46,720 (Direct) | View |
2023-03-01 Option Award | 2023-03-03 7:59 pm | N/A 2033-03-01 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 64,063 | $0 | 95,539 (Direct) | View |